Pharmacological characteristics and clinical study results of Pemigatinib (Pemazyre® Tablets), a selective fibroblast growth factor receptor (FGFR) inhibitor
2006 ◽
2016 ◽
Vol 12
(4)
◽
pp. 303-317
◽
2009 ◽
Vol 2
(1)
◽
pp. 30-36
◽